Company Profiles

driven by the PitchBook Platform

Abide Therapeutics

Abide Therapeutics
PRIVATE STATUS
21-30 EMPLOYEES
Series A LATEST DEAL TYPE
$6.6M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of an innovative therapeutic platform designed to target serine hydrolases. The company's therapeutic platform exploits the power of chemoproteomics to mine the serine hydrolase superfamily for novel drug targets, enabling health care providers to harness the therapeutic potential of serine hydrolases to yield drugs for treatment of a broad range of diseases in areas of unmet medical need.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 10835 Road to the Cure
  • Suite 250
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abide Therapeutics’s full profile, request a free trial.

Abide Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 29-Jul-2016 $6.6M 00.00 Completed Startup
3. Seed Round 00.00 Completed Startup
2. Grant 16-Jul-2013 $2.2M Completed Startup
1. Early Stage VC 17-Nov-2011 $2.2M $2.2M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Abide Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cure Alzheimer's Fund Angel (individual) 000 0000 000000 0
Cardinal Partners Venture Capital Minority 000 0000 000000 0

Abide Therapeutics Executive Team (13)

Name Title Board
Seat
Contact
Info
Alan Ezekowitz Ph.D Co-Founder, Board Member, President & Chief Executive Officer
Stan Blackburn Chief Financial Officer
Sapna Srivastava Ph.D Chief Financial & Strategy Officer
Dale Boger Co-Founder & Scientific Advisor
Keith Lenden Co-Founder

1 Former Executive

You’re viewing 5 of 13 executives. Get the full list »

Abide Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Alan Ezekowitz Ph.D Abide Therapeutics Co-Founder, Board Member, President & Chief Executive Officer 000 0000
Benjamin Cravatt Ph.D Self Scientific Co-Founder & Co-Chairman, Department of Molecular Medicine 000 0000
John Clarke Cardinal Partners Co-Founder, Chairman & Board Member 000 0000
Nancy Thornberry Self Board Member 000 0000
Paul Schimmel Ph.D Self Co-Founder & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »